338 related articles for article (PubMed ID: 19850903)
41. Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
Chirch L; Roche P; Fuhrer J
Ear Nose Throat J; 2008 Jan; 87(1):30-3. PubMed ID: 18357943
[TBL] [Abstract][Full Text] [Related]
42. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
[TBL] [Abstract][Full Text] [Related]
43. Use of newer antifungal therapies in clinical practice: what do the data tell us?
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
[TBL] [Abstract][Full Text] [Related]
44. Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B.
Alioglu B; Avci Z; Canan O; Ozcay F; Demirhan B; Ozbek N
Pediatr Hematol Oncol; 2007; 24(1):63-8. PubMed ID: 17130115
[TBL] [Abstract][Full Text] [Related]
45. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).
Jarque I; Tormo M; Bello JL; Rovira M; Batlle M; Julià A; Tabares S; Rivas C; Fernández-Sevilla A; García-Boyero R; Debén G; González-Campos J; Capote FJ; Sanz MA;
Med Mycol; 2013 Feb; 51(2):150-4. PubMed ID: 22712457
[TBL] [Abstract][Full Text] [Related]
46. Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
Cakir FB; Cakir E; Berrak SG; Uyan ZS; Canpolat C; Karakoc F; Dagli E
Pediatr Hematol Oncol; 2010 Sep; 27(6):422-34. PubMed ID: 20578809
[TBL] [Abstract][Full Text] [Related]
47. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R
Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
[TBL] [Abstract][Full Text] [Related]
48. A case of pulmonary aspergillosis with lack of response to caspofungin.
Rüchel R; Perske C; Glass B; Bäsecke J
Rev Iberoam Micol; 2006 Jun; 23(2):94-6. PubMed ID: 16854185
[TBL] [Abstract][Full Text] [Related]
49. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent.
Koss T; Bagheri B; Zeana C; Romagnoli MF; Grossman ME
J Am Acad Dermatol; 2002 Jun; 46(6):945-7. PubMed ID: 12063497
[TBL] [Abstract][Full Text] [Related]
50. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Howell A; Midturi J; Sierra-Hoffman M; Carpenter J; Hurley D; Winn R
Med Mycol; 2005 Nov; 43(7):651-5. PubMed ID: 16396251
[TBL] [Abstract][Full Text] [Related]
51. An update on the use of antifungal agents.
Martinez R
J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
[TBL] [Abstract][Full Text] [Related]
52. Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
Tsiodras S; Zafiropoulou R; Giotakis J; Imbrios G; Antoniades A; Manesis EK
Transpl Infect Dis; 2004 Mar; 6(1):37-40. PubMed ID: 15225226
[TBL] [Abstract][Full Text] [Related]
53. [New antifungal agents: voriconazole and caspofungin].
Dupont B
Arch Pediatr; 2003 Dec; 10 Suppl 5():592s-598s. PubMed ID: 15022787
[TBL] [Abstract][Full Text] [Related]
54. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Gasch O; Fernández N; Ayats J; Santin M
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
[No Abstract] [Full Text] [Related]
55. Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
Peláez T; Muñoz P; Guinea J; Valerio M; Giannella M; Klaassen CH; Bouza E
Clin Infect Dis; 2012 Feb; 54(3):e24-31. PubMed ID: 22247307
[TBL] [Abstract][Full Text] [Related]
56. Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients.
Veroux M; Corona D; Gagliano M; Sorbello M; Macarone M; Cutuli M; Giuffrida G; Morello G; Paratore A; Veroux P
Transplant Proc; 2007; 39(6):1838-40. PubMed ID: 17692627
[TBL] [Abstract][Full Text] [Related]
57. Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Rößler S; Bader O; Stölzel F; Sommer U; Spiess B; Geibel S; Buchheidt D; Groß U; Baretton G; Jacobs E; Ostrosky-Zeichner L
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28743702
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D
Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450
[TBL] [Abstract][Full Text] [Related]
59. Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis.
Cornely OA; Meems L; Herbrecht R; Viscoli C; van Amsterdam RG; Ruhnke M
Mycoses; 2015 Jan; 58(1):58-64. PubMed ID: 25530265
[TBL] [Abstract][Full Text] [Related]
60. Clinical activity of the new triazole drug voriconazole (UK 109, 496) against disseminated hepatosplenic aspergillosis in a patient with relapsed leukemia.
Hwang YK; Joo NH; Tee GY; Tan P; Tan L; Girija R
Haematologia (Budap); 2001; 31(1):73-80. PubMed ID: 11345409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]